Research is fundamental to the current and future success of PathWest, underpinning evidence-based practice and positively contributing to continuous improvements in benchtop to bedside care.

Throughout 2020/21, an extensive volume of research was undertaken by PathWest, both as primary and secondary researchers, as well as supporting multiple hospital research projects with the provision of diagnostic information.

PathWest’s involvement in research activities also provides opportunities for its workforce, encourages and improves collaborations - linking clinicians and surgeons from Health Service Providers, interstate and local university students and interstate academics with pathologists and scientists across all disciplines.

Research in numbers

During 2020/21, PathWest staff were:

• Involved in more than 359 active clinical research projects supported by the FSH Network Clinical Trials Management Unit.
• Involved in approximately 220 active research projects supported by the QEII Clinical Trials Management Unit.

PathWest has:

• 204 PathWest projects in RGS
• 81 PathWest research projects submitted for review
• Involvement in 14 COVID-19 research projects.